52
Participants
Start Date
December 31, 2004
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2009
intramyocardial injection of VEGF-A165/bFGF:placebo plasmid
The plasmid will be given at a total dose of 0.5 mg, 10 injections of 0,2 ml each into the region of reversible ischemia. The process of injecting the solution into each of ten points within the ischemic zone will take 20 to 40 seconds to minimize muscle disruption
Institute of Cardiology, Warsaw
Center of Oncology, Warsaw, Poland
UNKNOWN
Medical University of Warsaw
OTHER
Ministry of Scientific Research and Information Technology, Poland
OTHER_GOV
Polpharma Foundation for Development of Polish Pharmacy and Medicine
UNKNOWN
National Institute of Cardiology, Warsaw, Poland
OTHER